Phase 1 Trial of Arginine Hydrochloride for the Management of Diabetic Ketoacidosis in Type 2 Diabetes

NCT07167693 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

60

Enrollment

OTHER

Sponsor class

Conditions

Diabetes (DM)
Diabetic Ketoacidosis
Ketosis Prone Diabetes
Hyperglycaemia (Diabetic)

Interventions

DRUG: Arginine hydrochloride
DRUG: Sodium Chloride 0.9%

Sponsor

David K Carroll

Collaborators

[object Object]
[object Object]